West Pharmaceutical Services (WST) Change in Acquisitions & Divestments (2009 - 2014)

West Pharmaceutical Services (WST) has reported Change in Acquisitions & Divestments for 6 consecutive years, with $8.5 million the latest figure, recorded in Q3 2014.

• Quarterly Change in Acquisitions & Divestments rose 84.78% year-over-year to $8.5 million in Q3 2014, while the trailing twelve-month figure through Jun 2015 was $8.5 million (down 37.96% YoY) and the FY2014 annual result came in at $16.8 million, down 12.04% from the prior year.
• Change in Acquisitions & Divestments advanced to $8.5 million in Q3 2014 per WST's latest filing, from $3.3 million in the prior quarter.
• Over the last five years, Change in Acquisitions & Divestments for WST reached as high as $22.5 million in Q2 2012 and fell as low as -$9.6 million in Q1 2011.
• A 5-year average of $5.4 million and a median of $4.8 million in 2012 frame the typical range for Change in Acquisitions & Divestments.
• Annual changes were most pronounced in 2010 — Change in Acquisitions & Divestments jumped 963.64% — and 2011, when it plunged 1271.43%.
• Year by year, Change in Acquisitions & Divestments stood at $11.7 million in 2010, then tumbled by 182.05% to -$9.6 million in 2011, then jumped by 240.62% to $13.5 million in 2012, then plunged by 94.07% to $800000.0 in 2013, then jumped by 962.5% to $8.5 million in 2014.
• According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $8.5 million, $3.3 million, and $5.0 million for Q3 2014, Q2 2014, and Q1 2014 respectively.